Related Experiment Videos
Vaccines against veterinary helminths.
1AgReseach Limited, Wallaceville Animal Research Centre, Ward Street, Upper Hutt, New Zealand. wayne.hein@agresearch.co.nz
Veterinary Parasitology
|August 13, 2005
Summary
Developing veterinary vaccines against helminth parasites faces challenges. Research is exploring parasite glycans as alternative antigens, alongside protein-based approaches, to create effective commercial vaccines.
Area of Science:
- Veterinary immunology
- Parasitology
- Vaccine development
Background:
- Commercial vaccine development for veterinary helminths has primarily focused on protein antigens.
- Successful vaccines exist for cestode parasites using recombinant proteins.
- Challenges remain in formulating commercially viable vaccines for other significant helminth parasites, such as nematodes.
Purpose of the Study:
- To explore alternative antigen sources for veterinary helminth vaccines.
- To investigate the potential of parasite glycan moieties as vaccine candidates.
- To highlight the need for improved formulation and delivery strategies for helminth vaccines.
Main Methods:
- Review of existing research on veterinary helminth vaccines.
- Analysis of successes and limitations in protein-based vaccine development.
- Evaluation of emerging evidence for glycan-based antigens.
Main Results:
- Protein antigens have yielded notable successes in cestode vaccines but not universally for other helminths.
- Parasite glycan moieties are increasingly recognized as promising alternative vaccine antigens.
- Significant research gaps exist in vaccine formulation and delivery for helminth parasites.
Conclusions:
- Glycan-based antigens represent a potential alternative for veterinary helminth vaccine development.
- Further research is crucial for identifying protective antigens and optimizing vaccine delivery systems.
- Overcoming formulation and delivery challenges is key to achieving commercial success for helminth vaccines.